| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |